Antiretroviral endorsement issue

Imported from official source

Announcement

Safety Classified by Officially

Technical issue affecting prescriptions for emtricitabine with tenofovir disoproxil and dolutegravir

For individual prescriptions for emtricitabine with tenofovir disoproxil and dolutegravir that are dispensed from 1 November 2026 to 1 December 2026, Pharmac asks pharmacists to annotate and process the prescription as ‘endorsed', even though the current endorsement is for PSO supply for PEP. 

This will allow pharmacy claims to be processed.

Pharmac has identified a technical issue with the funding rule for emtricitabine with tenofovir disoproxil and dolutegravir that came into effect on 1 November 2026. The issue relates to the endorsement requirement associated with PSO supply for post-exposure prophylaxis (PEP).

The intent was for the endorsement requirement to apply only to PSO supply for PEP. However, the schedule system, cannot currently distinguish between PSO claims and individual prescriptions for emtricitabine with tenofovir disoproxil and dolutegravir.

Pharmac intends to resolve the issue through the 1 December 2026 update to the Schedule. 

Prescriber responsible for PEP use on PSO

When ordering on a PSO, the prescriber has the responsibility to ensure that the use is limited to PEP only and that at the time of supply the prescriber has obtained informed consent for the unregistered indication. 
 
When supplying on PSO, pharmacists are not required to confirm the use is for PEP or to ensure informed consent has been obtained. 

This is an extract. The publication continues at the source.

© Pharmac, licensed under CC BY 4.0. Licence

Read the original at the source: https://www.pharmac.govt.nz/news-and-resources/news/antiretroviral-endorsement-issue

Officially imported this from Pharmac’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Pharmac — imported from official source
Official source
https://www.pharmac.govt.nz/news-and-resources/news/rss RSS
Imported
November 09, 2026 03:31
Versions
1 recorded
Identity
https://www.pharmac.govt.nz/news-and-resources/news/antiretroviral-endorsement-issue

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.